Dyslipidemia in South Asian patients

Current Atherosclerosis Reports

Volumn 9, Issue 5, 2007, Pages 367-374

  Enas, Enas A ^a   Chacko, Vinod ^b   Pazhoor, Suraj George ^b   Chennikkara, Hancy ^b   Devarapalli, Heyer Paul ^b  

^a Coronary Artery Disease in Indians ^*  (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; ATORVASTATIN; CHOLESTEROL; EZETIMIBE; FENOFIBRATE; FISH OIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOPROTEIN A; LOVASTATIN PLUS NICOTINIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; PLACEBO; PRAVASTATIN; RESIN; ROSUVASTATIN; SIMVASTATIN; TRIACYLGLYCEROL;

AGE DISTRIBUTION; ASIAN; CARDIOVASCULAR RISK; CAUCASIAN; COMBINATION CHEMOTHERAPY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG METABOLISM; DRUG SAFETY; DYSLIPIDEMIA; ETHNIC DIFFERENCE; GENETIC PREDISPOSITION; HIGH RISK POPULATION; HUMAN; LIFESTYLE; LOW DRUG DOSE; METABOLIC SYNDROME X; MONOTHERAPY; PREVALENCE; REVIEW; SOUTH ASIA; UNSPECIFIED SIDE EFFECT;

ASIAN CONTINENTAL ANCESTRY GROUP; CORONARY ARTERY DISEASE; CORONARY DISEASE; DYSLIPIDEMIAS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERINSULINISM; LIPID METABOLISM; PREVALENCE; RISK FACTORS;

EID: 36148968851     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-007-0047-y     Document Type: Review

References (49)

1. Enas EA, Mehta J: Malignant coronary artery disease in young Asian Indians: thoughts on pathogenesis, prevention, and treatment. Clin Cardiol 1995, 18:131-135.
2. Enas EA: Coronary artery disease epidemic in Indians: a cause for alarm and call for action. J Indian Med Assoc 2000, 98:694-695, 697-702.
3. Enas EA: How to Beat the Heart Disease Epidemic among Soutb Asians: A Prevention and Management Guide for Asian Indians and their Doctors. Downers Grove: Advanced Heart Lipid Clinic; 2005.
4. Enas EA, Senthilkumar A, Chacko V, Puthumana N: Dyslipidemia among Indo-Asians: strategies for identification and management. Brit J Diabetes Vasc Dis 2005, 5:81-90.
5. Enas EA, Garg A, Davidson MA, et al.: Coronary heart disease and its risk factors in first-generation immigrant Asian Indians to the United States of America. Indian Heart J 1996, 48:343-353.
6. Enas EA, Senthilkumar A, Juturu V, Gupta R: Coronary artery disease in women. Indian Heart J 2001, 53:282-292.
7. Jafar TH, Jafary FH, Jessani S, Chaturvedi N: Heart disease epidemic in Pakistan: women and men at equal risk. Am Heart J 2005, 150:221-226.
8. Jafar TH: Women in Pakistan have a greater burden of clinical cardiovascular risk factors than men. Int J Cardiol 2006, 106:348-354.
9. Klatsky AL, Tekawa I, Armstrong MA, Sidney S: The risk of hospitalization for ischemic heart disease among Asian Americans in northern California. Am J Public Health 1994, 84:1672-1675.
10. Palaniappan L, Wang Y, Fortmann SP: Coronary heart disease mortality for six ethnic groups in California, 1990-2000. Ann Epidemiol 2004, 14:499-506.
11. Indrayan A: Forecasting vascular disease cases and assocaitd mortalty in India. http://www.whoindia.org/LinkFiles/ Commision_on_Macroeconomic_and_Health_Bg_P2_Forecasting_ vascular_diseaseu_case_and_associated_mortality_in_India.pdf. Acessed April 1, 2007.
12. Enas EA, Senthilkumar A, Chennikkara H, Bjurlin MA: Prudent diet and preventive nutrition from pediatrics to geriatrics: current knowledge and practical recommendations. Indian Heart J 2003, 55:310-338.
13. Watanabe H, Soderlund S, Soro-Paavonen A, et al.: Decreased high-density lipoprotein (HDL) particle size, pre-beta-, and large HDL subspecies concentration in Finnish low-HDL families. Relationship with intima-media thickness. Arterioscler Thromb Vasc Biol 2006, 26:897-902
14. Cromwell WC: High-density lipoprotein asociations with coronary heart disease: Does measurement of cholesterol content give the best result? J Clin Lipidol 2007, 1:57-64.
15. Bhalodkar NC, Blum S, Rana T, et al.: Comparison of levels of large and small high-density lipoprotein cholesterol in Asian Indian men compared with Caucasian men in the Framingham Offspring Study. Am J Cardiol 2004, 94:1561-1563.
16. Superko HR, Enas EA, Kotha P, et al.: High-density lipoprotein subclass distribution in individuals of asian Indian descent. the National Asian Indian Heart Disease Project. Prev Cardiol 2005, 8:81-86.
17. Asztalos BF, Le Maulf F, Dallal GE, et al.: Comparison of the effects of high doses of rosuvastatin versus atorvastatin on the subpopulations of high-density lipoproteins. Am J Cardiol 2007, 99:681-685.
18. Grundy SM, Cleeman JI, Merz CN, et al.: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004, 110:227-239.
19. Joseph A, Kutty VR, Soman CR: High risk for coronary heart disease in Thiruvananthapuram City: a study of serum lipids and other risk factors. Indian Heart J 2000, 52:29-35.
20. Mora S, Szklo M, Otvos JD, et al.: LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 2007, 192:211-217.
21. Bhalodkar NC, Blum S, Enas EA: Accuracy of the ratio of triglycerides to high-density lipoprotein cholesterol for predicting low-density lipoprotcin cholesterol particle sizes, phenotype B, and particle concentrations among asian indians. Am J Cardiol 2006, 97:1007-1009.
22. Tewari S, Kumar S, Kapoor A, et al.: Premature coronary artery disease in North India: an angiography study of 1971 patients. Indian Heart J 2005, 57:311-318.
23. Smith J, Cianflone K, Al-Amri M, Sniderman A: Body composition and the apoB/apoA-I ratio in migrant Asian Indians and white Caucasians in Canada. Clin Sci (Lond) 2006, 111:201-207.
24. Ridker PM, Rifai N, Cook NR, et al.: Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA 2005, 294:326-333.
25. Joshi P, Islam S, Pais P, et al.: Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. JAMA 2007, 297:286-294.
26. Alberti KG, Zimmet P, Shaw J: The metabolic syndrome - a new worldwide definition. Lancet 2005, 366:1059-1062.
27. Reddy KS, Prabhakaran D, Chaturvedi V, et al.: Methods for establishing a surveillance system for cardiovascular diseases in Indian industrial populations. Bull World Health Organ 2006, 84:461-469.
28. Lip GY, Barnett AH, Bradbury A, et al.: Ethnicity and cardiovascular disease prevention in the United Kingdom: a practical approach to management. J Hum Hypertens 2007, 21:183-211.
29. Miller Gi, Beckles GL, Maude GH, et al.: Ethnicity and other characteristics predictive of coronary heart disease in a developing community: principal results of the St James Survey, Trinidad. Int J Epidemiol 1989, 18:808-817.
30. Forouhi NG, Sattar N, Tillin T, et al.: Do known risk factors explain the higher coronary heart disease mortality in South Asian compared with European men? Prospective follow-up of the Southall and Brent studies, UK. Diabetologia 2006, 49:2580-2588.
31. Enas EA, Chacko V, Senthilkumar A, et al.: Elevated lipoprotein(a)-a genetic risk factor for premature vascular disease in people with and without standard risk factors: a review. Dis Mon 2006, 52:5-50.
32. Gambhir JK, Kaur H, Gambhir DS, Prabhu. KM: Lipoprotein(a) as an independent risk factor for coronary artery disease in patients below 40 years of age. Indian Heart J 2000, 52:411-415.
33. Bhopal R, Fischbacher C, Vartiainen E, et al.: Predicted and observed cardiovascular disease in South Asians: application of FINRISK, Framingham and SCORE models to Newcastle Heart Project data. J Public Health (Oxf) 2005, 27:93-100.
34. Ballantyne CM, Weiss R, Moccetti T, et al.: Efficacy and safety of rosuvastatin 40 mg alone or in combination with ezetimibe in patients at high risk of cardiovascular disease (results from the EXPLORER study). Am J Cardiol 2007, 99:673-680.
35. Nakamura H, Arakawa K, Itakura H, et al.: Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial. Lancet 2006, 368:1155-1163.
36. Matsuzaki M, Kita T, Mabuchi H, et al.: Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia. Circ J 2002, 66:1087-1095.
37. Deedwania P, Haffner S, Was J, Stein M: Comparison of statin treatment of hypercholesterolemic patients in ethenically diverse populations with and without diabetes J Am Coll Cardiol 2007, 49(Suppl):327A.
38. Patel JV, Gupta S, Lie F, Hughes EA: Efficacy and safety of atorvastatin in South Asian patients with dyslipidemia: an open label noncomparative pilot study. Vasc Health and Risk Manage 2005, 1:351-356.
39. Jayaram S, Jain MM, Naikawadi AA, et al.: Comparative evaluation of the efficacy, safety, and tolerability of rosuvastatin 10 mg with atorvastatin 10 mg in adult patients with hypercholesterolaemia: the first Indian study. J Indian Med Assoc 2004, 102:48-50, 52.
40. Lee E, Ryan S, Birmingham B, et al.: Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment. Clin Pharmacol Ther 2005, 78:330-341.
41. Berg K, Dahlen G, Christophersen B, et al.: Lp(a) lipoprotein level predicts survival and major coronary events in the Scandinavian Sinivastatin Survival Study. Clin Genet 1997, 52:254-261.
42. Carlson LA, Hamsten A, Asplund A: Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid. J Intern Med 1989, 226:271-276.
43. Morgan JM, Capuzzi DM, Baksh RI, et al.: Effects of extended-release niacin on lipoprotein subclass distribution. Am J Cardiol 2003, 91:1432-1436.
44. Sharma M, Sharma DR, Singh V, et al.: Evaluation of efficacy and safety of fixed dose lovastatin and niacin(ER) combination in asian Indian dyslipidemic patients: a multicentric study. Vasc Health Risk Manage 2006, 2:87-93.
45. Kashyap ML, McGovern ME, Berra K, et al.: Long-term safety and efficacy of a once-daily niacin/lovastatin formulation for patients with dystipidemia. Am J Cardiol 2002, 89:672-678.
46. Aarabi M, Jackson PR: Predicting coronary risk in UK South Asians: an adjustment method for Framingham-based tools. Eur J Cardiovasc Prev Rebabil 2005, 12:46-51.
47. JBS: joint British recommendations on prevention of coronary heart disease in clinical practice. Heart 1998, 80(Suppl 2):S1-S29.
48. American Association of Physicians of Indian Origin (AAPI) Concensus Statement on Management of Dyslipidemia among Asian Indians. http://www.AAPIUSA.org/aapicare/aapihealth and nutrition. Accessed April 1, 2007.
49. Boden WE, O'Rourke RA, Teo KK, et al.: Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007, 357:1503-1516.